Wiluna Mining Corporation Limited
Use the PDF link above to access the reasons for this decision. The HTML version will be available shortly.
Identitii Limited – Variation of Orders
Use the PDF link above to access the media release. The HTML version will be available shortly.
Humm Group Limited – Panel Makes Interim Orders
The Panel has made interim orders in response to an application dated 23 January 2026 and received by the Panel on 26 January 2026 by Akat Investments Pty Ltd in relation to the affairs of Humm Group Limited (see TP26/005) (Application).
Identitii Limited – Declaration of Unacceptable Circumstances and Orders
The Panel has made a declaration of unacceptable circumstances (Annexure A) and final orders (Annexure B) in relation to an application dated 16 January 2026 by Mitchell Asset Management Pty Ltd as trustee for the Mitchell Asset Management Go‑Innovation Finance Fund in relation to the affairs of Identitii Limited (see TP26/003).
Background
Identitii is an ASX-listed company (ASX code: ID8).
Humm Group Limited – Panel Receives Application
The Panel has received an application from Akat Investments Pty Ltd in relation to the affairs of Humm Group Limited.
Details of the application, as submitted by the applicant, are below.
A sitting Panel has not been appointed at this stage and no decision has been made whether to conduct proceedings. The Panel makes no comment on the merits of the application.
Details
Humm is an ASX-listed company (ASX: HUM).
The applicant is a shareholder of Humm.
Identitii Limited – Undertaking
The Panel has accepted an undertaking from Identitii Limited (Identitii) in relation to the application dated 16 January 2026 by Mitchell Asset Management Pty Ltd as trustee for the Mitchell Asset Management Go‑Innovation Finance Fund (see TP26/003).
Identitii has undertaken:
Mayne Pharma Group Limited
Introduction
- The Panel, Yasmin Allen AM (sitting President), Michael Borsky KC and Richard Phillips, made a declaration of unacceptable circumstances in response to an application by Mayne Pharma in relation to its affairs. Cosette proposed to acquire Mayne Pharma via a scheme of arrangement. The application concerned Cosette’s re-evaluation of its intentions in relation to Mayne Pharma’s Australian manufacturing site, which put the prospects of receiving FIRB approval of the scheme at risk.
Identitii Limited – Panel Receives Application
The Panel has received an application from Mitchell Asset Management Pty Ltd as trustee for the Mitchell Asset Management Go‑Innovation Finance Fund in relation to the affairs of Identitii Limited.
Details of the application, as submitted by the applicant, are below.
A sitting Panel has not been appointed at this stage and no decision has been made whether to conduct proceedings. The Panel makes no comment on the merits of the application.
Details
Identitii is an ASX listed company (ASX code: ID8).
The applicant is a shareholder of Identitii.